Last reviewed · How we verify

NCT05877287

Effect of Awareness-Based Stress Reducatıon Program Applıed to Parents Wıth A Chıld Wıth Autısm

Completed NA Last updated 9 February 2026
What this trial tests

NA trial testing mindfulness-based stress reduction program in DEPRESSION in 96 participants. Completed in 25 September 2025.

Timeline
1 June 2023
Primary endpoint
25 September 2023
25 September 2025

Quick facts

Lead sponsorNecmettin Erbakan University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment96
Start date1 June 2023
Primary completion25 September 2023
Estimated completion25 September 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Necmettin Erbakan University

Who can join

18 and older, any sex, with DEPRESSION or ANXIETY. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research was planned to examine the effect of mindfulness-based stress reduction program applied to parents with autistic children on the level of depression, anxiety, stress and hopelessness.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of mindfulness-based stress reduction program

Trials testing the same drug.

Other Necmettin Erbakan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05877287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing